Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma

Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality

(2015) A. McIntyre et al.   EMBO Molecular Medicine

High Expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis

(2014) Suyanee Thongchot et al.   Asian Pacific Journal of Cancer Prevention

Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma

(2014) Hiroki Goto et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

COMMD1/Murr1 Reinforces HIV-1 Latent Infection through IκB-α Stabilization

(2014) Manabu Taura et al.   JOURNAL OF VIROLOGY

A novel EGFP-expressing nude mice with complete loss of lymphocytes and NK cells to study tumor-host interactions

(2014) Kumiko Gotoh et al.   BioScience Trends

Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

(2013) Reza Bayat Mokhtari et al.   BMC CANCER

Comparative analysis of ER stress response into HIV protease inhibitors: Lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway

(2013) Manabu Taura et al.   FREE RADICAL BIOLOGY AND MEDICINE

Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma

(2013) Kulthida Vaeteewoottacharn et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer

(2013) Sampurna Chatterjee et al.   JOURNAL OF CLINICAL INVESTIGATION

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

(2013) Jonathan Welti et al.   JOURNAL OF CLINICAL INVESTIGATION

Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma

(2012) Y.-L. Hu et al.   CANCER RESEARCH

Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy

(2012) A. McIntyre et al.   CLINICAL CANCER RESEARCH

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

(2012) Shahid A Khan et al.   GUT

Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α

(2012) Yeo-Jung Kim et al.   INTERNATIONAL JOURNAL OF CANCER

Hypoxia Inducible Factor Expression in Intrahepatic Cholangiocarcinoma

(2011) Yuji Morine et al.   HEPATO-GASTROENTEROLOGY

Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma

(2011) Siobhan C. McKay et al.   HPB

Gene expression and hypoxia in breast cancer

(2011) Elena Favaro et al.   Genome Medicine

Targeted Therapy for Biliary Tract Cancer

(2011) Junji Furuse et al.   Cancers

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) F. Eckel et al.   ANNALS OF ONCOLOGY

Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB

(2010) Wunchana Seubwai et al.   CANCER SCIENCE

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intrahepatic Cholangiocarcinoma

(2009) Itaru Endo et al.   ANNALS OF SURGERY

Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas

(2009) Nathalie Guedj et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

(2009) Andrew X Zhu et al.   LANCET ONCOLOGY

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

(2009) A. Rapisarda et al.   MOLECULAR CANCER THERAPEUTICS

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

(2008) T André et al.   BRITISH JOURNAL OF CANCER

Cholangiocarcinoma: lessons from Thailand

(2008) Banchob Sripa et al.   CURRENT OPINION IN GASTROENTEROLOGY